KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Long-Term Deferred Tax (2016 - 2018)

Historic Long-Term Deferred Tax for Fulgent Genetics (FLGT) over the last 3 years, with Q3 2018 value amounting to $929000.0.

  • Fulgent Genetics' Long-Term Deferred Tax rose 334074.07% to $929000.0 in Q3 2018 from the same period last year, while for Sep 2018 it was $929000.0, marking a year-over-year increase of 334074.07%. This contributed to the annual value of $126000.0 for FY2017, which is 13333.33% up from last year.
  • According to the latest figures from Q3 2018, Fulgent Genetics' Long-Term Deferred Tax is $929000.0, which was up 334074.07% from $592000.0 recorded in Q2 2018.
  • Fulgent Genetics' 5-year Long-Term Deferred Tax high stood at $929000.0 for Q3 2018, and its period low was $27000.0 during Q3 2017.
  • Over the past 3 years, Fulgent Genetics' median Long-Term Deferred Tax value was $86000.0 (recorded in 2016), while the average stood at $266666.7.
  • In the last 5 years, Fulgent Genetics' Long-Term Deferred Tax plummeted by 6860.47% in 2017 and then skyrocketed by 334074.07% in 2018.
  • Fulgent Genetics' Long-Term Deferred Tax (Quarter) stood at $54000.0 in 2016, then soared by 133.33% to $126000.0 in 2017, then surged by 637.3% to $929000.0 in 2018.
  • Its last three reported values are $929000.0 in Q3 2018, $592000.0 for Q2 2018, and $505000.0 during Q1 2018.